GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanjivani Paranterals Ltd (BOM:531569) » Definitions » Revenue

Sanjivani Paranterals (BOM:531569) Revenue : ₹494.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Sanjivani Paranterals Revenue?

Sanjivani Paranterals's revenue for the three months ended in Dec. 2023 was ₹149.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹494.2 Mil. Sanjivani Paranterals's Revenue per Share for the three months ended in Dec. 2023 was ₹14.95. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹49.41.

During the past 12 months, the average Revenue per Share Growth Rate of Sanjivani Paranterals was 52.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -0.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -23.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Sanjivani Paranterals's highest 3-Year average Revenue per Share Growth Rate was 13.20% per year. The lowest was -48.80% per year. And the median was -6.35% per year.


Sanjivani Paranterals Revenue Historical Data

The historical data trend for Sanjivani Paranterals's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanjivani Paranterals Revenue Chart

Sanjivani Paranterals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 243.61 160.11 247.07 303.76 352.43

Sanjivani Paranterals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.22 78.73 125.81 140.03 149.63

Competitive Comparison of Sanjivani Paranterals's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sanjivani Paranterals's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanjivani Paranterals's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanjivani Paranterals's Revenue distribution charts can be found below:

* The bar in red indicates where Sanjivani Paranterals's Revenue falls into.



Sanjivani Paranterals Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹494.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanjivani Paranterals  (BOM:531569) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sanjivani Paranterals Revenue Related Terms

Thank you for viewing the detailed overview of Sanjivani Paranterals's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanjivani Paranterals (BOM:531569) Business Description

Traded in Other Exchanges
N/A
Address
L. B. S. Marg, 205, P N Kothari Industrial Estate, Bhandup (West), Mumbai, MH, IND, 400078
Sanjivani Paranterals Ltd is a pharmaceutical company principally engaged in providing pharmaceutical products and services. The main product range of the company includes oral solids, small-volume parenteral, and sterile powder formulations. The products offered by the company are anti-biotic, anti-emetic, anti-tuberculosis, anti-diabetic, anti-malarial, anti-fungal, calcium and vitamin, multivitamin, sedative, cardiovascular, anti-gout, and others. The company also provides Liquid Injection, Dry powder Injection, Capsules, Drops, and others. The firm sells its products in India and internationally.

Sanjivani Paranterals (BOM:531569) Headlines

No Headlines